BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24283933)

  • 21. Impact of polymorphisms in the DC-SIGNR neck domain on the interaction with pathogens.
    Gramberg T; Zhu T; Chaipan C; Marzi A; Liu H; Wegele A; Andrus T; Hofmann H; Pöhlmann S
    Virology; 2006 Apr; 347(2):354-63. PubMed ID: 16413044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of CD209L tandem repeats polymorphism with susceptibility to human immunodeficiency virus-1 infection, disease progression, and treatment outcomes: a Moroccan cohort study.
    Fayssel N; Bensghir R; Ouladlahsen A; Abdelghaffar H; Sodqi M; Lahlou K; Benjelloun S; Marhoum El Filali K; Ezzikouri S; Wakrim L
    Clin Microbiol Infect; 2015 May; 21(5):513.e1-5. PubMed ID: 25656622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional genetic variants in DC-SIGNR are associated with mother-to-child transmission of HIV-1.
    Boily-Larouche G; Iscache AL; Zijenah LS; Humphrey JH; Mouland AJ; Ward BJ; Roger M
    PLoS One; 2009 Oct; 4(10):e7211. PubMed ID: 19809496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The VNTR polymorphism of the DC-SIGNR gene and susceptibility to HIV-1 infection: a meta-analysis.
    Li H; Yu XM; Wang JX; Hong ZH; Tang NL
    PLoS One; 2012; 7(9):e42972. PubMed ID: 22957026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of DC-SIGN and DC-SIGNR Repeat Regions with Susceptibility to Pulmonary Tuberculosis in Zahedan, Southeastern Iran.
    Naderi M; Hashemi M; Soroush N; Amininia S; Taheri M
    Acta Med Iran; 2016 May; 54(5):308-12. PubMed ID: 27309478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variant in CD209 promoter is associated with severity of liver disease in chronic hepatitis C virus infection.
    Ryan EJ; Dring M; Ryan CM; McNulty C; Stevenson NJ; Lawless MW; Crowe J; Nolan N; Hegarty JE; O'Farrelly C
    Hum Immunol; 2010 Aug; 71(8):829-32. PubMed ID: 20470843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relationship between intrauterine infection and the gene polymorphism of DC-SIGN/DC-SIGNR in the pregnant women of HBV positive].
    Liu SR; Weng HB; Wu J; Zhang ZD; Zeng YM; Tian HF
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):331-3. PubMed ID: 22338216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between the Number of Repeats in the Neck Regions of L-SIGN and Augmented Virus Replication and Immune Responses in Dengue Hemorrhagic Fever.
    Liu KS; Chen PM; Wang L; Lee IK; Yang KD; Chen RF
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles.
    Lozach PY; Amara A; Bartosch B; Virelizier JL; Arenzana-Seisdedos F; Cosset FL; Altmeyer R
    J Biol Chem; 2004 Jul; 279(31):32035-45. PubMed ID: 15166245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of DC-SIGN and DC-SIGNR genetic polymorphism in Chinese Han population].
    Wang H; Hu YD; Wang CH; Dong XM; Li LX; Liu FP; Yan LB; Zhou P; Tong XD; Shi LL; Xiao X; Zhu TF; Zhou BP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Aug; 23(4):466-9. PubMed ID: 16883544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of a novel C-type lectin-like gene, LSECtin: demonstration of carbohydrate binding and expression in sinusoidal endothelial cells of liver and lymph node.
    Liu W; Tang L; Zhang G; Wei H; Cui Y; Guo L; Gou Z; Chen X; Jiang D; Zhu Y; Kang G; He F
    J Biol Chem; 2004 Apr; 279(18):18748-58. PubMed ID: 14711836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DC-SIGN (dendritic cell-specific ICAM-grabbing non-integrin) and DC-SIGN-related (DC-SIGNR): friend or foe?
    Soilleux EJ
    Clin Sci (Lond); 2003 Apr; 104(4):437-46. PubMed ID: 12653690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The DC-SIGNR 7/5 genotype is associated with high dendritic cell counts and their subsets in patients infected with HIV-1.
    Chaudhary O; Bala M; Singh J; Hazarika A; Kumar R; Luthra K
    J Clin Immunol; 2013 May; 33(4):788-97. PubMed ID: 23354840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin 28B.rs12979860 genotype does not affect hepatitis C viral load in Egyptians with genotype 4 chronic infection.
    Abdelwahab SF; Zakaria Z; Allam WR; Hamdy S; Mahmoud MA; Sobhy M; Rewisha E; Waked I
    Arch Virol; 2015 Nov; 160(11):2833-7. PubMed ID: 26280523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Length variation of DC-SIGN and L-SIGN neck-region has no impact on tuberculosis susceptibility.
    Barreiro LB; Neyrolles O; Babb CL; van Helden PD; Gicquel B; Hoal EG; Quintana-Murci L
    Hum Immunol; 2007 Feb; 68(2):106-12. PubMed ID: 17321900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DC-SIGN (CD209) Promoter -336 A/G polymorphism is associated with dengue hemorrhagic fever and correlated to DC-SIGN expression and immune augmentation.
    Wang L; Chen RF; Liu JW; Lee IK; Lee CP; Kuo HC; Huang SK; Yang KD
    PLoS Negl Trop Dis; 2011 Jan; 5(1):e934. PubMed ID: 21245921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The polymorphisms in DC-SIGNR affect susceptibility to HIV type 1 infection.
    Wichukchinda N; Kitamura Y; Rojanawiwat A; Nakayama EE; Song H; Pathipvanich P; Auwanit W; Sawanpanyalert P; Iwamoto A; Shioda T; Ariyoshi K
    AIDS Res Hum Retroviruses; 2007 May; 23(5):686-92. PubMed ID: 17530994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection.
    Knapp S; Warshow U; Ho KM; Hegazy D; Little AM; Fowell A; Alexander G; Thursz M; Cramp M; Khakoo SI
    Gastroenterology; 2011 Jul; 141(1):320-5, 325.e1-2. PubMed ID: 21600205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein E allele frequencies in chronic and self-limited hepatitis C suggest a protective effect of APOE4 in the course of hepatitis C virus infection.
    Mueller T; Fischer J; Gessner R; Rosendahl J; Böhm S; van Bömmel F; Knop V; Sarrazin C; Witt H; Marques AM; Kovacs P; Schleinitz D; Stumvoll M; Blüher M; Bugert P; Schott E; Berg T
    Liver Int; 2016 Sep; 36(9):1267-74. PubMed ID: 26880346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control of progression towards liver fibrosis and hepatocellular carcinoma by SOCS3 polymorphisms in chronic HCV-infected patients.
    Jadid FZ; Chihab H; Alj HS; Elfihry R; Zaidane I; Tazi S; Badre W; Marchio A; El Filali KM; Tahiri M; Saile R; Pineau P; Ezzikouri S; Benjelloun S
    Infect Genet Evol; 2018 Dec; 66():1-8. PubMed ID: 30172885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.